NeuroSense Therapeutics L... (NRSNW)
undefined
undefined%
At close: undefined
0.25
0.00%
After-hours Dec 13, 2024, 02:06 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 97.00K 89.00K 3.00K 3.00K -
Gross Profit -97.00K -89.00K -3.00K -3.00K -
Operating Income -12.05M -13.55M -5.59M -2.89M -1.24M
Interest Income 178.00K 91.00K - 61.00K 18.00K
Pretax Income -11.28M -12.34M -4.04M -2.83M -1.22M
Net Income -10.11M -11.20M -2.50M -2.83M -1.23M
Selling & General & Admin 4.78M 7.14M 2.50M 393.00K 337.00K
Research & Development 7.27M 6.42M 3.08M 2.50M 898.00K
Other Expenses - - - - -
Operating Expenses 10.29M 13.55M 5.59M 2.89M 1.24M
Interest Expense 550.00K 15.00K 1.15M 1K 5.00K
Selling & Marketing Expenses - - - - -
Cost & Expenses 10.29M 13.55M 5.59M 2.89M 1.24M
Income Tax - -1.14M -1.55M 1K 5.00K
Shares Outstanding (Basic) 13.64M 11.50M 1.94M 1.94M 1.94M
Shares Outstanding (Diluted) 13.64M 11.50M 1.94M 1.94M 1.94M
EPS (Basic) -0.83 -0.97 -1.29 -1.46 -0.63
EPS (Diluted) -0.83 -0.97 -1.29 -1.46 -0.63
EBITDA -10.63M -13.38M -2.88M -2.83M -1.25M
Depreciation & Amortization 97.00K 89.00K 3.00K 3.00K 1.24M